Tandem Diabetes Care Inc (TNDM)
47.30
+0.38
(+0.80%)
USD |
NASDAQ |
May 17, 16:00
47.30
0.00 (0.00%)
After-Hours: 20:00
Tandem Diabetes Care Gross Profit (Quarterly): 94.67M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 94.67M |
December 31, 2023 | 93.30M |
September 30, 2023 | 89.75M |
June 30, 2023 | 101.74M |
March 31, 2023 | 82.91M |
December 31, 2022 | 115.52M |
September 30, 2022 | 104.42M |
June 30, 2022 | 101.95M |
March 31, 2022 | 91.09M |
December 31, 2021 | 113.73M |
September 30, 2021 | 96.74M |
June 30, 2021 | 92.45M |
March 31, 2021 | 73.29M |
December 31, 2020 | 90.56M |
September 30, 2020 | 65.31M |
June 30, 2020 | 54.39M |
March 31, 2020 | 50.26M |
December 31, 2019 | 60.27M |
September 30, 2019 | 50.68M |
June 30, 2019 | 49.90M |
March 31, 2019 | 33.35M |
December 31, 2018 | 41.54M |
September 30, 2018 | 21.80M |
June 30, 2018 | 15.09M |
Date | Value |
---|---|
March 31, 2018 | 11.40M |
December 31, 2017 | 17.47M |
September 30, 2017 | 11.87M |
June 30, 2017 | 8.002M |
March 31, 2017 | 6.753M |
December 31, 2016 | 10.06M |
September 30, 2016 | -1.577M |
June 30, 2016 | 8.176M |
March 31, 2016 | 6.928M |
December 31, 2015 | 13.46M |
September 30, 2015 | 5.513M |
June 30, 2015 | 4.801M |
March 31, 2015 | 2.808M |
December 31, 2014 | 6.535M |
September 30, 2014 | 4.397M |
June 30, 2014 | 3.449M |
March 31, 2014 | 0.866M |
December 31, 2013 | 1.188M |
September 30, 2013 | 2.533M |
June 30, 2013 | 0.4059M |
March 31, 2013 | 2.040M |
December 31, 2012 | -0.4472M |
September 30, 2012 | -0.9008M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
49.90M
Minimum
Jun 2019
115.52M
Maximum
Dec 2022
83.65M
Average
90.82M
Median
Gross Profit (Quarterly) Benchmarks
Insulet Corp | 306.80M |
Abbott Laboratories | 5.501B |
Stryker Corp | 3.333B |
Twist Bioscience Corp | 30.88M |
Perspective Therapeutics Inc | -- |